Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. The company is headquartered in Waltham, Massachusetts and currently employs 1,778 full-time employees. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Mr. Olivier Loeillot est le President de Repligen Corp, il a rejoint l'entreprise depuis 2023.
Quelle est la performance du prix de l'action RGEN ?
Le prix actuel de RGEN est de $113.88, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Repligen Corp ?
Repligen Corp appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quel est la capitalisation boursière de Repligen Corp ?
La capitalisation boursière actuelle de Repligen Corp est de $6.4B
Est-ce que Repligen Corp est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 18 analystes ont établi des notations d'analystes pour Repligen Corp, y compris 7 achat fort, 16 achat, 5 maintien, 0 vente et 7 vente forte